Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellula...
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not diagnosed and treated accordingly. CRS generally occ...
Alternative Titles
Full title
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_94bdf1610dc14128a162118ec5b3bed8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94bdf1610dc14128a162118ec5b3bed8
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2020-000742
